Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ...Middle East

PR Newswire - News
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., April 2, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted 19 newly-hired employees options to purchase an aggregate of 131,000 shares of Akebia's...

Read More Details
Finally We wish PressBee provided you with enough information of ( Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) )

Also on site :